Navigation Links
Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
Date:11/19/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Salt block unexpectedly stretches in Sandia experiments 8980 1Salt block unexpectedly stretches in Sandia experiments 8980 2OMTECs Opening Keynote Emphasizes Increasing Demand for Orthopaedic Procedures 49906 1OMTECs Opening Keynote Emphasizes Increasing Demand for Orthopaedic Procedures 49906 2MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 1MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 2MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 3